Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merkel Cell Carcinoma
Related studies linked through entity extraction aliases.
Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Immunological Variables Associated to ICI Toxicity in Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)
- Status
- COMPLETED
- Phase
- PHASE1
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
L19IL2/L19TNF in Skin Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC
- Status
- COMPLETED
- Phase
- NA
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
- Status
- RECRUITING
- Phase
- PHASE3
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IFx-Hu2.0 Expanded Access Program
- Status
- AVAILABLE
- Phase
- N/A
Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines
- Status
- UNKNOWN
- Phase
- NA